NCT03327883 Retrospective Review of FDG PET MRI Management of Patients With Muscle Invasive Bladder Cancer Status COMPLETED Phase N/A
NCT03325231 Factors Influencing Patient Choice of Bladder Reconstruction Following Radical Cystectomy Status COMPLETED Phase N/A
NCT03317158 Modern Immunotherapy in BCG-Unresponsive, BCG-Relapsing and High Risk BCG-Naive Non-Muscle Invasive Urothelial Carcinoma of the Bladder Status RECRUITING Phase PHASE1/PHASE2
NCT03307200 Unmet Supportive Care Needs in Bladder Cancer Patients Undergoing Radical Cystectomy Status COMPLETED Phase N/A
NCT03298958 Secondary Prevention Trial of Rapamycin in Patients With Resected Non-muscle Invasive Bladder Cancer Status WITHDRAWN Phase PHASE3
NCT03296306 Four Cycles Versus Six Cycles of Cisplatin-based Chemotherapy in Metastatic Urothelial Carcinoma Status UNKNOWN Phase PHASE3
NCT03291028 Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma Status ACTIVE_NOT_RECRUITING Phase N/A
NCT03289962 A Study of Autogene Cevumeran (RO7198457) as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Tumors Status COMPLETED Phase PHASE1
NCT03266900 A Superiority Trial to Compare Re-resection of High-grade T1 Bladder Urothelial Carcinoma to no Re-resection for Improving Progression Free Survival Status TERMINATED Phase EARLY_PHASE1
NCT03257293 A Trial of a Modified Cystoscopy Method to Reduce Pain Perception Status COMPLETED Phase NA
NCT03245736 Tisotumab Vedotin Continued Treatment in Patients With Solid Tumors. Status COMPLETED Phase PHASE2
NCT03232541 The Effects of Acupuncture and the Therapist´s Communication on Chemotherapy Induced Nausea and Vomiting Status COMPLETED Phase NA
NCT03224182 A Study of Intravesical Qapzola (Apaziquone) as a Surgical Adjuvant in Participants Undergoing Transurethral Resection of Bladder Tumor (TURBT) Status TERMINATED Phase PHASE3
NCT03216525 Alvimopan Versus Placebo in Patients Undergoing Radical Cystectomy on an Enhanced Recovery Protocol Status RECRUITING Phase PHASE3
NCT03212651 Study Evaluating Neoadjuvant Pembrolizumab Monotherapy in Patients With Muscle-Invasive Bladder Cancer to Explore in Vivo the Mechanisms of Action of Pembrolizumab Status COMPLETED Phase PHASE2
NCT03193788 Pemetrexed Maintenance in Patients With Urothelial Carcinoma Who Completed First Line Platinum-based Chemotherapy Status UNKNOWN Phase PHASE3